Freestone Grove Partners LP Harmony Biosciences Holdings, Inc. Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 25,921 shares of HRMY stock, worth $882,091. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,921Holding current value
$882,091% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
317Shares Held
43.8MCall Options Held
1.05MPut Options Held
310K-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$173 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$57.6 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$56.8 Million0.02% of portfolio
-
State Street Corp Boston, MA1.65MShares$56.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.01B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...